No Data
No Data
Immutep Data From Phase II Trial Presented at CTOS
Immutep Announces Data From Phase II Trial In Soft Tissue Sarcoma Presented At CTOS 2024 Annual Meeting
Daiichi Sankyo to Showcase TURALIO Research in Patients With Tenosynovial Giant Cell Tumor at CTOS
Malaysia Closing Bell on Nov 13 | TENAGA Was the Top Gainer of FBM KLCI
Malaysia Closing Bell on Nov 12 | IOICORP Was the Top Gainer of FBM KLCI
CTOS Climbs on Stronger 3Q Profit but Analysts Cut Earnings Forecasts, TPs as Group Flags Revenue Risks Ahead
No Data
No Data